Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach
Open Access
- 24 February 2017
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 61 (4) , 563-580
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive and incurable neurodegenerative disease. Although several compounds have shown promising results in preclinical studies, their translation into clinical trials has failed. This clinical failure is likely due to the inadequacy of the animal models that do not sufficiently reflect the human disease. Therefore, it is important to optimize drug target selection by identifying those that overlap in human and mouse pathology. We have recently characterized the transcriptional profiles of motor cortex samples from sporadic ALS (SALS) patients and differentiated these into two subgroups based on differentially expressed genes, which encode 70 potential therapeutic targets. To prioritize drug target selection, we investigated their degree of conservation in superoxide dismutase 1 (SOD1) G93A transgenic mice, the most widely used ALS animal model. Interspecies comparison of our human expression data with those of eight different SOD1G93A datasets present in public repositories revealed the presence of commonly deregulated targets and related biological processes. Moreover, deregulated expression of the majority of our candidate targets occurred at the onset of the disease, offering the possibility to use them for an early and more effective diagnosis and therapy. In addition to highlighting the existence of common key drivers in human and mouse pathology, our study represents the basis for a rational preclinical drug development.Keywords
Funding Information
- Italian Ministry of Education, Universities and Research (CTN01_00177_817708)
This publication has 100 references indexed in Scilit:
- ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actionsTranslational Psychiatry, 2013
- Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosisBrain and Behavior, 2013
- Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer DiseaseJournal of Biological Chemistry, 2011
- IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotectionBrain, Behavior, and Immunity, 2011
- Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of AstrocytesNeurotherapeutics, 2010
- Dopamine D2receptor signaling modulates mutant ataxin‐1 S776 phosphorylation and aggregationJournal of Neurochemistry, 2010
- GOSemSim: an R package for measuring semantic similarity among GO terms and gene productsBioinformatics, 2010
- Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosisExperimental Neurology, 2008
- Database resources of the National Center for Biotechnology InformationNucleic Acids Research, 2007
- Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasLProceedings of the National Academy of Sciences, 2006